UK-Swiss trade deal held up over pharma row

British government departments are split over the issue.

POLITICO
What If Europe became a beacon for biotech innovation?

Visit the post for more.

POLITICO
Unleashing Europe’s biotech prowess requires radical reinvention

The bloc is all too often sitting on the sidelines, asking “what’s allowed?” rather than “what’s possible?”

POLITICO
Covid-19 vaccine-maker BioNTech to acquire former rival CureVac

Both German companies have continued mRNA programs on so-called cancer vaccines.

POLITICO
Poland hits a wall trying to curb Big Pharma’s profits

The EU’s ‘competitiveness’ mantra appears to be swaying more countries to back the pharmaceutical industry.

POLITICO
Europe faces growing threat of fake drugs, Europol warns

There has been a rise in sub-standard, falsely labelled or falsified medicines.

POLITICO
These are the most deadly pathogens — so why aren’t drug companies targeting them?

Despite calls to step up efforts, investment in antimicrobial resistance is still insufficient.

POLITICO
Why Big Pharma might think twice about running away to America

A major drug pricing crackdown in the US is threatening drug companies’ bottom lines.

POLITICO